Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

In addition to COVID-19, new vaccines have been presented to combat flu, the herpes-zoster virus, meningococcus and pneumococcus.

Dr. José García Arumi and Dr. Anna Duarri from the Ophthalmology research group at Vall Hebron Recerca lead the project. 

Vall d’Hebron hosted the 14th International NOTES-WIDER-Barcelona course on 22 and 23 November, which welcomed a hundred international professionals in Surgery, Clinical endoscopy and Gastroenterology.

The Ministry of Science and Innovation granted more than €1.4 million to the project "Early molecular nanoDIAGnostics of Brain tumours using ImmunePET (DIAGBI)" with the participation of Vall d’Hebron through the Molecular Medicine Imaging Group.

All the activities associated with virtual and augmented reality, robotics, simulation, 3D, entrepreneurship and research came to an end after five days.

An analysis of thrombi would allow the cause of a stroke to be detected and therefore permit the selection of an appropriate treatment to prevent a stroke and to carry out a more thorough follow-up.

Biopsies obtained by flexible bronchoscopy have been used to analyze which patients have sequelae in the lung in order to recommend, if necessary, the administration of corticosteroids as a treatment.

The EVOLUTION trial is currently in phase IIb and it will evaluate the effect of the Vafidemstat drug on cognitive effects and the negative effects deriving from the illness.

The team led by Dr. Matilde E. LLeonart has observed the presence of elevated levels of syntenin-1 in chemotherapy-resistant cells and cancer stem cells.

Among the 108 Spanish scientists recognised on the 2021 Web of Science Group list, two from Vall d’Hebron Research Institute stand out: Dr Maria Buti and Dr Xavier Montalban.

La Setmana de la Innovació i la Ciència a Vall d’Hebron seran cinc dies plens d’activitats relacionades amb la realitat virtual i augmentada, la robòtica, la simulació, el 3D, l’emprenedoria o la recerca.

The AECC Research Grants for 2021 will drive the research headed by Dr Fernanda da Silva and Dr Eva Colás.

The jury unanimously recognised her efforts in the fight against COVID-19 and the cooperation with the care sector for dependent elderly people.

Within the framework of the project “Cooperative Cohort COVID-19”, a mobile application will allow citizens to transfer their data under certain conditions and thus actively collaborate in research projects.

The grant will allow to carry out a validation study of a digital tool for monitoring patients with advanced diabetic kidney disease.

The analysis aimed to identify trends in indicators of quality of care in the surgical treatment of adult scoliosis, such as complications, reinterventions and impact on the quality of life of patients with spinal deviation.

Dr Albert Salazar, director of Vall d’Hebron and Chairman of the EUHA highlighted “the significance of this alliance, which allows us to establish synergies with Europe and thus improve patient care”.

Vall d’Hebron is looking for volunteers over the age of 18 who have received the Pfizer-BioNTech Comirnaty vaccine against COVID-19 at least 6 months ago.

Prostate cancer, testicle cancer, mental health and preventing suicide among men were the focus of the charity organisation Movember, which since 2003 has funded more than 1,250 projects associated with male health around the world.

The Fight Kids Cancer initiative (a union of three European cancer associations: Imagine for Margo, Kick Cancer and Kriibskrank Kanner Foundation) is the funding institution.

L’Associació Pulseras Candela consolida la seva col·laboració amb una nova aportació de 50.000€ al projecte del Dr. Miquel Segura i la Dra. Roberta Antonelli del VHIR.

As of tomorrow, Lleida will be hosting the 19th Congress of the Spanish Society of Neuroscience (SENC). This is a biennial event, which this year will be held from 3 to 5 November in la Llotja, the Lleida Exhibition Centre.

Hi participaran 300 persones en set centres repartits per tota Catalunya, entre els quals es troba Vall d'Hebron.

The Aligning Science Across Parkinson's (ASAP) initiative has awarded the grant to a project coordinated by Dr. Miquel Vila, head of the Neurodegenerative Diseases research group at the Vall d'Hebron Research Institute (VHIR).